Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001712470 | SCV000604314 | benign | not provided | 2022-09-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001513222 | SCV001720798 | benign | Mevalonic aciduria; Porokeratosis 3, disseminated superficial actinic type; Hyperimmunoglobulin D with periodic fever | 2023-12-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001712470 | SCV001940765 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22246419, 27884173, 27190114) |
Genome Diagnostics Laboratory, |
RCV002263715 | SCV002542341 | benign | Autoinflammatory syndrome | 2016-12-12 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV003488641 | SCV004234018 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 28% of patients studied by a panel of primary immunodeficiencies. Number of patients: 25. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001712470 | SCV005237674 | benign | not provided | criteria provided, single submitter | not provided |